Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
ProCare welcomes the reduction in age of bowel screening for Māori and Pacific patients; long overdue
This item is over 2 years old; some content may no longer be current
+Undoctored
ProCare welcomes the reduction in age of bowel screening for Māori and Pacific patients; long overdue
Thursday 19 May 2022, 03:20 PM

Leading healthcare provider ProCare has today welcomed the reduction in the age of bowel screening for Māori and Pacific patients from 60 to 50 with an additional $10.096 million in the next financial year.
Dr Allan Moffitt, Clinical Director at ProCare says: “This decision has been long overdue, and we have been lobbying for this reduction in screening age for a number of years now.
“Bowel cancer affects Māori and Pasifika patients at a much earlier age than non-Māori and Pasifika, so screening at a lower age makes sense, will significantly reduce the inequities in our health system and ultimately save lives,” he concludes.